Pd64-01 the Water Study Clinical Results – A Phase Iii Blinded Randomized Trial of Aquablation vs. Turp With Blinded Outcome Assessment for Moderate-To-Severe Luts in Men With BPH

Journal of Urology - Netherlands
doi 10.1016/j.juro.2018.02.2973
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

PRECIOUS: PREvention of Complications to Improve OUtcome in Elderly Patients With Acute Stroke. Rationale and Design of a Randomised, Open, Phase III, Clinical Trial With Blinded Outcome Assessment

European Stroke Journal
NeurologyCardiovascular MedicineCardiology
2018English

Assessment of Probiotic Effects on Colorectal Surgery Complications: A Double Blinded, Randomized Clinical Trial

Biomedical Research and Therapy
BiochemistryMedicineGeneticsMolecular Biology
2019English

Randomized, Blinded Trial of Weekend vs Daily Prednisone in Duchenne Muscular Dystrophy

Neurology
Neurology
2011English

The Clinical Efficacy of Kinesio Tape for Shoulder Pain: A Randomized, Double-Blinded, Clinical Trial

Journal of Orthopaedic and Sports Physical Therapy
MedicinePhysical TherapySports TherapyRehabilitationSports Science
2008English

Protocol for TRAUMADORNASE: A Prospective, Randomized, Multicentre, Double-Blinded, Placebo-Controlled Clinical Trial of Aerosolized Dornase Alfa to Reduce the Incidence of Moderate-To-Severe Hypoxaemia in Ventilated Trauma Patients

Trials
MedicinePharmacology
2020English

Mp01-01 Water vs Water Ii: Aquablation Therapy for Benign Prostatic Hyperplasia

Journal of Urology
Urology
2019English

A Blinded Randomized Clinical Trial of Manual Therapy and Physiotherapy for Chronic Back and Neck Complaints: Physical Outcome Measures

Complementary Therapies in Medicine
Alternative MedicineManual TherapySpecialized NursingAdvancedComplementary
1993English

Study Protocol: Efficacy of Oral Alitretinoin Versus Oral Cyclosporine a in Patients With Severe Recurrent Vesicular Hand Eczema (ALICsA): A Randomised Prospective Open-Label Trial With Blinded Outcome Assessment

BMJ Open
Medicine
2018English

Erratum To: Pasireotide LAR Maintains Inhibition of GH and IGF-1 in Patients With Acromegaly for Up to 25 Months: Results From the Blinded Extension Phase of a Randomized, Double-Blind, Multicenter, Phase III Study

Pituitary
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy